Laurel Lenz

University of Colorado System — United States

Immunology and Microbiology · Life Sciences

35h-index4.1kcitations139works0.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune Cell Function and Interaction(46), Cancer Immunotherapy and Biomarkers(30), Immune Response and Inflammation(23), Immunotherapy and Immune Responses(20), Listeria monocytogenes in Food Safety(13)

Publications139 total

Review 2: "NK Cells Undergo Transcriptional and Functional Reprogramming following Streptococcus Pneumoniae Infection"
2025Open Access
Reviews of "NK Cells Undergo Transcriptional and Functional Reprogramming following Streptococcus Pneumoniae Infection"
2025Open Access
Maternal Inflammation Likely Drives Impaired Immune Responses to Respiratory Syncytial Virus in HIV-Exposed Uninfected Infants
The Journal of Infectious Diseases·2025· 1 citedOpen Access
Comparison of immune responses to respiratory syncytial virus in infancy, childhood, and adulthood using an in vitro model of human respiratory infection
ImmunoHorizons·2025· 2 citedOpen Access
Synaptopodin is necessary for <i>Shigella flexneri</i> intercellular spread
2023Open Access
Supplementary Figure from Targeting Treg-Expressed STAT3 Enhances NK-Mediated Surveillance of Metastasis and Improves Therapeutic Response in Pancreatic Adenocarcinoma
2023Open Access
Supplementary Figure 2 from FLT3L Release by Natural Killer Cells Enhances Response to Radioimmunotherapy in Preclinical Models of HNSCC
2023Open Access
Supplementary Figure 6 from FLT3L Release by Natural Killer Cells Enhances Response to Radioimmunotherapy in Preclinical Models of HNSCC
2023Open Access
Supplementary Figure from Targeting Treg-Expressed STAT3 Enhances NK-Mediated Surveillance of Metastasis and Improves Therapeutic Response in Pancreatic Adenocarcinoma
2023Open Access
Supplementary Figure 1 from FLT3L Release by Natural Killer Cells Enhances Response to Radioimmunotherapy in Preclinical Models of HNSCC
2023Open Access
Supplementary Figure 4 from FLT3L Release by Natural Killer Cells Enhances Response to Radioimmunotherapy in Preclinical Models of HNSCC
2023Open Access
Supplementary Figure 6 from FLT3L Release by Natural Killer Cells Enhances Response to Radioimmunotherapy in Preclinical Models of HNSCC
2023Open Access
Supplementary Figure from Targeting Treg-Expressed STAT3 Enhances NK-Mediated Surveillance of Metastasis and Improves Therapeutic Response in Pancreatic Adenocarcinoma
2023Open Access
Supplementary Figure from Targeting Treg-Expressed STAT3 Enhances NK-Mediated Surveillance of Metastasis and Improves Therapeutic Response in Pancreatic Adenocarcinoma
2023Open Access
Supplementary Figure from Targeting Treg-Expressed STAT3 Enhances NK-Mediated Surveillance of Metastasis and Improves Therapeutic Response in Pancreatic Adenocarcinoma
2023Open Access
Supplementary Figure 4 from FLT3L Release by Natural Killer Cells Enhances Response to Radioimmunotherapy in Preclinical Models of HNSCC
2023Open Access
Supplementary Figure 1 from FLT3L Release by Natural Killer Cells Enhances Response to Radioimmunotherapy in Preclinical Models of HNSCC
2023Open Access
Data from FLT3L Release by Natural Killer Cells Enhances Response to Radioimmunotherapy in Preclinical Models of HNSCC
2023Open Access
Data from FLT3L Release by Natural Killer Cells Enhances Response to Radioimmunotherapy in Preclinical Models of HNSCC
2023Open Access
Supplementary Figure from Targeting Treg-Expressed STAT3 Enhances NK-Mediated Surveillance of Metastasis and Improves Therapeutic Response in Pancreatic Adenocarcinoma
2023Open Access
page 1 of 7Next →

Frequent Co-authors

Michael J. Bevan(7), Jessica Humann(6), Rebecca L. Schmidt(6), Sarah E. Clark(5), Manira Rayamajhi(5), Holly Filak(4), Staci J. Kearney(4), Christine Delgado(4), Charles D. Mills(3), Daniel A. Portnoy(3), Krista K. Hill(3), Karl Andreasen(3), Tracy V. Condon(3), David W. H. Riches(3), Emily M. Eshleman(3), Lei Jin(2), Jennifer Mogan(2), Heather M. Knowles(2), Anne‐Laure Perraud(2), John C. Cambier(2)